Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/2011
01/19/2011CN101948900A Method for extracting hydrolyzed collagen from bovine cartilage
01/19/2011CN101948899A Method for preparing angiotensin converting enzyme inhibitory peptide (ACEIP) by using enzymatic degradation on mussel-digested protein
01/19/2011CN101948898A Method for preparing nano oligopeptide collagen
01/19/2011CN101948896A Integrated preparation method of multi-function milk casein active peptides
01/19/2011CN101948894A Gradient dilution feed enzyme membrane coupling reaction and application thereof for preparing scale collagen polypeptide
01/19/2011CN101948844A Protein preparation method of alpha interferon analogue
01/19/2011CN101948837A Method for producing human insulin growth factor-1 in recombinant Escherichia coli
01/19/2011CN101948543A Fusion protein and coding gene and application thereof
01/19/2011CN101948542A Nanoliposome antivenom active enzyme A2 and enteropathogen specific composite IgY and application thereof
01/19/2011CN101948538A Method for refining chicken egg yolk antibodies against Escherichia coli
01/19/2011CN101948537A Method for extracting chicken yolk antibody against infectious bursal disease
01/19/2011CN101948535A Method for separating immunoglobulin IgY from chicken blood
01/19/2011CN101948533A Preparation method of fish skin collagen
01/19/2011CN101948530A Method of preparing lactalbumin scale purification
01/19/2011CN101948529A Hydrophobic chromatography separating and purifying method for efficiently purifying metal ion binding proteins
01/19/2011CN101948528A Fibrinolytic activated protein from cantharis, preparation method and application thereof
01/19/2011CN101948526A Method for separating and purifying pulmonary alveoli surface active proteins (SP-B and SP-C)
01/19/2011CN101948524A Multi-phosphopeptide-enriched casein hydrolyzate and preparation method thereof
01/19/2011CN101948520A Preparation method of sparganosis mansoni ES antigen
01/19/2011CN101948519A Mytilus coruscus foot adhesive protein as well as encoding sequence and preparation method thereof
01/19/2011CN101948518A Method for preparing functional protein RJCPs by royal jelly and application
01/19/2011CN101948514A Method for improving total component content of colistin sulphate
01/19/2011CN101948509A Affinity peptide for tissue-type plasminogen activator and fragment of activator, and application thereof
01/19/2011CN101948508A Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof
01/19/2011CN101948505A Method for binding pathologic protein by using conjugated polyelectrolyte
01/19/2011CN101948504A Method of using ion-exchange chromatography medium for assisting protein renaturation and application thereof
01/19/2011CN101225103B Vitelline polietilenglicol primary precipitation degreasing technology
01/19/2011CN101072791B S-alkyl-sulphenyl protection groups in solid-phase synthesis
01/18/2011US7872108 Using centrifugation and filtration to recover protein aggregates comprisng metallic nanoclusters for use as apototic therapeutic in treatment of cell proliferative disorders
01/18/2011US7871817 in vitro method for producing a T-cell expressing a T-cell receptor (TCR); mediate an oncogen-specific T-cell response
01/18/2011US7871798 Mammalian cells that express VEGF-D polypeptides
01/18/2011US7871794 Using in vitro translation system comprising bacterial cell extract and foldase to produce polypeptides
01/18/2011CA2408008C Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
01/13/2011WO2011005488A1 Refolding proteins using a chemically controlled redox state
01/13/2011WO2011004129A1 Use of a co-product from a method for extracting lysozyme from egg whites, in order to obtain at least one basic egg white protein
01/13/2011WO2011003935A1 Parathyroid hormone related protein antagonists
01/13/2011WO2010128033A3 Method for purification of target polypeptides
01/13/2011WO2010101903A3 Compositions, methods and kits for preparing plasminogen; and plasmin prepared therefrom
01/13/2011US20110009604 Method for Concentrating, Purifying and Removing Prion Protein
01/13/2011US20110009601 Labeled protein and method for obtaining the same
01/13/2011US20110009598 Method of producing cell extract for cell-free protein synthesis
01/13/2011US20110008900 Depletion of plasma proteins
01/13/2011US20110008869 Engineered proteases for affinity purification and processing of fusion proteins
01/13/2011US20110008458 Process for removing growth factors from platelets
01/13/2011US20110008249 Proteins with high immunoreactivity and method for their production
01/13/2011US20110005930 Ffe media and ffe methods comprising volatile separation media
01/13/2011CA2765881A1 Refolding proteins using a chemically controlled redox state
01/12/2011EP2273270A1 Method and apparatus for the preparation and/or analysis of biochemical carriers
01/12/2011EP2272961A1 Process for producing recombinant albumin with reduced mannosylation
01/12/2011EP2272872A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof
01/12/2011EP2272870A1 Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
01/12/2011EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate
01/12/2011EP2272378A1 Fractionation of protein containing mixtures
01/12/2011EP2271382A1 Two-stage ultrafiltration/diafiltration
01/12/2011EP1880215B1 Compositions and methods for detection of sirolimus
01/12/2011EP1453858B1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
01/12/2011EP1109831B1 Cyctotoxic peptides modified by bulky or lipophilic moieties
01/12/2011CN1865283B Solid phase polypeptide synthesis preparation method for salcatonin
01/12/2011CN1777435B Method of purifying polypeptides by simulated moving bed chromatography
01/12/2011CN101945888A Recovery of hydrophobic peptides from oils
01/12/2011CN101942496A Method for preparing virus analogs of nervous necrosis viruses
01/12/2011CN101942023A Human epidermic growth factor ferritin heavy chain subunit fusion protein, constructing method and use thereof
01/12/2011CN101942022A Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof
01/12/2011CN101942014A Food grade phycocyanin and preparation method thereof
01/12/2011CN101942010A Method for promoting solid phase synthesis of balsam pear MC-JJ0106 polypeptide analogue by microwaves and application thereof
01/12/2011CN101942009A Compound medicament for separating crude proteins from monosodium glutamate-fermented waste liquor and preparation method thereof
01/12/2011CN101406827B Method for producing capillary electrochromatography monolithic column made from silicon dioxide-titanic oxide integral material and uses thereof
01/11/2011US7868150 Nucleic acids encoding T2R taste receptors
01/11/2011US7868145 Magnetic particles containing a copolymer core, magnetic layer and silicon layer
01/11/2011US7868139 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
01/11/2011US7868137 Search for cancer markers by a novel screening method
01/11/2011US7868136 Search for cancer markers by a screening method
01/11/2011US7867730 production system for a recombinant glycoprotein having therapeutic value in humans using a methylotrophic, thermotolerant yeast; host system for mass production of recombinant hepatitis vaccines
01/11/2011US7867704 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections
01/11/2011US7867699 inexpensively synthesizing large quantities of an essentially pure, biologically active, glycosylated Dkk protein, including mammalian and human Dkk proteins
01/06/2011WO2011001963A1 Method for purification of antibody using porous membrane having amino group and alkyl group both bound to graft chain immobilized on porous base material
01/06/2011WO2011000848A1 Solid phase peptide synthesis of peptide alcohols
01/06/2011WO2010113035A3 Peptide-based beta turn mimetics
01/06/2011WO2010111633A3 Antibody composition with altered fab sialylation
01/06/2011WO2010103546A3 A polynucleotide and polypeptide sequence and methods thereof
01/06/2011WO2010099477A3 Polypeptide structural motifs associated with cell signaling activity
01/06/2011US20110004948 Immunoglobulin 2
01/06/2011US20110003977 Process for removing organic solvents from a biomass
01/06/2011US20110003976 Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by non flammable solvents
01/06/2011US20110003975 Method of denaturing whey protein
01/06/2011US20110003972 Stabilizing polypeptides which have been exposed to urea
01/06/2011US20110003379 Chimeric autoprocessing polypeptides and uses thereof
01/06/2011US20110003276 Blood separation and concentration system
01/06/2011US20110002935 Antibody purification
01/05/2011EP2270044A1 Liquid immunoglobulin G (lgG) product
01/05/2011EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
01/05/2011EP2270025A1 Solid phase peptide synthesis of peptide alcohols
01/05/2011EP2268656A1 Fluorogenic peptides and their method of production
01/05/2011EP2268392A1 Method for isolating polypeptides
01/05/2011EP2069385B1 Immobilization of membrane proteins onto supports via an amphiphile
01/05/2011EP1875237B1 Docetaxel immunoassay
01/05/2011EP1723417B1 C20orf23 as modifier of the igfr pathway and methods of use
01/05/2011EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor
01/05/2011EP1426101B1 Compatible-multiphase organic solvent system
01/05/2011CN101939329A Amino acid pairing-based self assembling peptides and methods